Miguel Teran/LinkedIn
Sep 10, 2026, 16:07
Miguel Teran: Why ROTEM Will Redefine Major Bleeding Management
Miguel Teran, Anesthesiologist at Hospital Luis F. Nachón, shared a post on LinkedIn:
”A prediction: in a few years, managing major bleeding without understanding ROTEM will be comparable to practicing medicine without knowing how to read an ECG.
We are moving from fixed transfusion ratios such as 1:1:1 toward individualized, goal-directed hemostatic resuscitation.
ROTEM helps us answer the question that really matters:
What is this patient actually missing?
Fibrinogen?
Coagulation factors?
Platelet contribution?
Is there fibrinolysis?
The goal is no longer simply to transfuse blood products.
The goal is precision hemostasis.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters